This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anwar, K. Articles by Inzuka, M. Search for Related Content PubMed PubMed Citation Articles by Anwar, K. Articles by Inzuka, M.

Presence of ras Oncogene Mutations and Human Papillomavirus DNA in Human Prostate Carcinomas

Department of Pathology, Fukui Medical School, Matsuoka Fukui 910-11 [K. A., K. N., H. N.]; Department of Pathology, School of Medicine, Mie University, 2-174 Edobashi, Tsu [T. S., R. Y.]; and Department of Biochemistry, Fukui Medical School, Matsuoka, Fukui 910-11 [M. I.], Japan

The frequency of H-ras, K-ras, and N-ras mutations and the presence of high-risk human papillomavirus (HPV 16, 18, and 33) DNA were studied in 75 paraffin-embedded specimens obtained from 68 Japanese patients with a variety of prostate carcinomas by using polymerase chain reaction and DNA hybridization with sequence-specific oligonucleotides. Ten specimens each of normal and benign hyperplastic prostatic tissues from the same number of patients were also examined for this analysis. Of 68 carcinoma cases, ras gene mutations were present in 16 cases (24%) and HPV DNAs in 28 cases (41%). Eleven mutations were detected in codon 61 of H-ras, 4 in codon 12 of N-ras, and 2 in codon 61 of K-ras, HPV 16, 18, and 33 DNAs were found in 11, 17, and 5 cases, respectively. Eight of the 16 cases with ras mutation also harbored HPV DNAs. The frequency of ras mutations and the HPV infection increased in patients with advanced stages of the tumor and with the higher Gleason score. There was the predominant presence of H-ras codon 61.2 (CAGCTG) mutation and HPV 18 DNA in prostatic carcinomas metastasizing to the bone. None of the normal or benign hyperplastic prostatic specimens contained either ras mutation or HPV DNA. Our results suggest that ras gene mutations and HPV infections are relatively frequent, at least in prostate carcinoma of Japanese patients. These two factors appear to be related to the progression of the tumor. Moreover, H-ras codon 61.2 mutation and HPV 18 infection may have some predictive roles for bone metastasis in prostate carcinoma.

¹ To whom requests for reprints should be addressed, at Department of Pathology, Fukui Medical School, 23-3 Shimoaizuki, Matsuoka, Fukui 910-11, Japan.

Received 4/20/92. Accepted 8/24/92.

This article has been cited by other articles:

				S Youshya, K Purdie, J Breuer, C Proby, M T Sheaf, R T D Oliver, and S Baithun Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis J. Clin. Pathol., February 1, 2005; 58(2): 207 - 210. [Abstract] [Full Text] [PDF]

				R. Berger, P. G. Febbo, P. K. Majumder, J. J. Zhao, S. Mukherjee, S. Signoretti, K. T. Campbell, W. R. Sellers, T. M. Roberts, M. Loda, et al. Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells Cancer Res., December 15, 2004; 64(24): 8867 - 8875. [Abstract] [Full Text] [PDF]

				R. Foley, D. Hollywood, and M. Lawler Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease Endocr. Relat. Cancer, September 1, 2004; 11(3): 477 - 488. [Abstract] [Full Text] [PDF]

				L. Klampfer, J. Huang, G. Corner, J. Mariadason, D. Arango, T. Sasazuki, S. Shirasawa, and L. Augenlicht Oncogenic Ki-Ras Inhibits the Expression of Interferon-responsive Genes through Inhibition of STAT1 and STAT2 Expression J. Biol. Chem., November 21, 2003; 278(47): 46278 - 46287. [Abstract] [Full Text] [PDF]

				H.-O. Adami, H. Kuper, S.-O. Andersson, R. Bergstrom, and J. Dillner Prostate Cancer Risk and Serologic Evidence of Human Papilloma Virus Infection: A Population-based Case-Control Study Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 872 - 875. [Abstract] [Full Text] [PDF]

				Y. Yasunaga, K. Nakamura, C. M. Ewing, W. B. Isaacs, B. Hukku, and J. S. Rhim A Novel Human Cell Culture Model for the Study of Familial Prostate Cancer Cancer Res., August 1, 2001; 61(16): 5969 - 5973. [Abstract] [Full Text] [PDF]

				E. Ruijter, C. van de Kaa, G. Miller, D. Ruiter, F. Debruyne, and J. Schalken Molecular Genetics and Epidemiology of Prostate Carcinoma Endocr. Rev., February 1, 1999; 20(1): 22 - 45. [Abstract] [Full Text]